Orgenesis Inc. (OTCMKTS:ORGS – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $0.36 and traded as low as $0.35. Orgenesis shares last traded at $0.35, with a volume of 100 shares changing hands.
Orgenesis Stock Down 12.5%
The company has a market capitalization of $1.81 million, a price-to-earnings ratio of -0.03 and a beta of 3.63. The business has a 50-day moving average price of $0.31 and a 200-day moving average price of $0.36.
About Orgenesis
Orgenesis Inc is a biotechnology company focused on cell and gene therapy development and the technologies needed to manufacture these treatments closer to the point of patient care. Its work combines therapeutic programs with bioprocessing systems intended to support the production of personalized, autologous cell therapies.
The company’s technology platform includes its Point-of-Care (POCare) ecosystem and Mobile Processing Units (MPUs). These systems are designed to provide controlled, modular environments for processing patient-derived cells at hospitals, clinics, and other treatment sites, with the goal of reducing reliance on centralized manufacturing facilities.
Orgenesis has pursued collaborations with academic institutions, healthcare organizations, and biotechnology partners in the United States and internationally.
Further Reading
- Five stocks we like better than Orgenesis
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
